SCHEMBL86318

SCHEMBL86318

COc1ccc2c(c1)C(=O)c1ccccc1OC2

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.82
MAPT P10636 5/20 0.82
SMN1; SMN2 Q16637 3/20 0.82
RAB9A P51151 2/20 0.82
HPGD P15428 2/20 0.82
KDM4E B2RXH2 1/20 0.82
NPC1 O15118 1/20 0.82
GAA P10253 1/20 0.82
ALOX12 P18054 1/20 0.82
TDP1 Q9NUW8 1/20 0.82
MAOB P27338 5/20 0.57
MAPK14 Q16539 3/20 0.55
KMT2A Q03164 1/20 0.53
PPIB P23284 1/20 0.51
METAP1 P53582 1/20 0.49
MIF P14174 1/20 0.48
PKM P14618 1/20 0.47
TSHR P16473 1/20 0.47
ATM Q13315 1/20 0.47
CYP19A1 P11511 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL653579 0.90 ALDH1A1 (1.00) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL87317 0.90 ALDH1A1 (0.83) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL13382951 0.82 ALDH1A1 (0.71) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL5766822 0.82 ALDH1A1 (0.71) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL10922096 0.82 MAPT (0.70) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL10922670 0.81 ALDH1A1 (0.54) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL10623445 0.80 ALDH1A1 (0.64) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL5337855 0.80 MAPK14 (0.67) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL30080967 0.80 KDM4E (0.63) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD
SCHEMBL2315303 0.80 KDM4E (0.63) ALDH1A1MAPTSMN1; SMN2RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2053095-B2 Ink composition and inkjet recording method using the same FUJIFILM CORP (JP) 2017-02-22 EP disclosed
EP-2053095-B1 Ink composition and inkjet recording method using the same FUJIFILM CORP (JP) 2014-03-26 EP disclosed
US-8129447-B2 Ink composition and inkjet recording method using the same FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
US-8129447-B2 Ink composition and inkjet recording method using the same FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
EP-2053095-A2 Ink composition and inkjet recording method using the same Fujifilm Corporation (JP) 2009-04-29 EP disclosed
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME RB1, IK, NOX1 ALDH1A1 440/4885MAPT 2087/4885SMN1; SMN2 2151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.